Understanding the pathobiology underlying IPF initiation and progression has been facilitated by the characterization of high effect size variants in the surfactant protein C (SFTPC) gene found in patients with familial pulmonary fibrosis, sporadic IPF, and childhood interstitial lung disease. Here, SFTPC is linked to interstitial lung disease.